Cargando…
Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast
Chemotherapy is commonly used for the treatment of breast cancer. However, the resistance to chemotherapeutic agents, often mediated by multidrug resistance (MDR) mechanisms, is a common occurrence. The present study examined the expression of several MDR-related proteins (MRPs) in invasive ductal c...
Autores principales: | LI, WEIQUAN, SONG, MAOMIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186596/ https://www.ncbi.nlm.nih.gov/pubmed/25295098 http://dx.doi.org/10.3892/ol.2014.2435 |
Ejemplares similares
-
EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
por: Hwangbo, Won, et al.
Publicado: (2013) -
Identification of aberrant gene expression during breast ductal
carcinoma in situ progression to invasive ductal
carcinoma
por: Song, Guiqin, et al.
Publicado: (2019) -
Expression of CD 133 in Invasive Ductal Carcinoma of Breast
por: Utnal, Preeti Ashok, et al.
Publicado: (2020) -
Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer
por: Liu, Jiannan, et al.
Publicado: (2016) -
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)